Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Aubry

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|February 1, 2012
Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosisAlix Pantel, Stéphanie Petrella, Nicolas Veziris, et al.
The Biochemical Journal|September 11, 2013
Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motionAlka Agrawal, Mélanie Roué, Claus Spitzfaden, et al.
Journal of Clinical Microbiology|January 31, 2014
Illustration of the difficulty of identifying Streptococcus equi strains at the subspecies level through a case of endocarditis in an immunocompetent manAnne Sophie Daubié, Carine Defrance, Aurélie Renvoisé, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine modelJulien Poissy, Alexandra Aubry, Christine Fernandez, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 23, 2020
Development and validation of a UPLC-MS/MS method for simultaneous quantification of levofloxacin, ciprofloxacin, moxifloxacin and rifampicin in human plasma: Application to the therapeutic drug monitoring in osteoarticular infectionsBenoit LLopis, Christian Funck-Brentano, Nadine Tissot, et al.
Critical Care (London, England)|June 27, 2020
Usefulness of point-of-care multiplex PCR to rapidly identify pathogens responsible for ventilator-associated pneumonia and their resistance to antibiotics: an observational studyCharles-Edouard Luyt, Guillaume Hékimian, Isabelle Bonnet, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2016
Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosisAlix Pantel, Stéphanie Petrella, Nicolas Veziris, et al.
Emerging Infectious Diseases|April 21, 2022
atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment FailureLaure Fournier Le Ray, Alexandra Aubry, Wladimir Sougakoff, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2024
Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosisThomas Maitre, Alexandre Godmer, Céline Mory, et al.
The Biochemical Journal|July 23, 2013
Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxesAurélie Bouige, Amélie Darmon, Jérémie Piton, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|February 1, 2012
Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosisAlix Pantel, Stéphanie Petrella, Nicolas Veziris, et al.
The Biochemical Journal|September 11, 2013
Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motionAlka Agrawal, Mélanie Roué, Claus Spitzfaden, et al.
Journal of Clinical Microbiology|January 31, 2014
Illustration of the difficulty of identifying Streptococcus equi strains at the subspecies level through a case of endocarditis in an immunocompetent manAnne Sophie Daubié, Carine Defrance, Aurélie Renvoisé, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine modelJulien Poissy, Alexandra Aubry, Christine Fernandez, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 23, 2020
Development and validation of a UPLC-MS/MS method for simultaneous quantification of levofloxacin, ciprofloxacin, moxifloxacin and rifampicin in human plasma: Application to the therapeutic drug monitoring in osteoarticular infectionsBenoit LLopis, Christian Funck-Brentano, Nadine Tissot, et al.
Critical Care (London, England)|June 27, 2020
Usefulness of point-of-care multiplex PCR to rapidly identify pathogens responsible for ventilator-associated pneumonia and their resistance to antibiotics: an observational studyCharles-Edouard Luyt, Guillaume Hékimian, Isabelle Bonnet, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2016
Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosisAlix Pantel, Stéphanie Petrella, Nicolas Veziris, et al.
Emerging Infectious Diseases|April 21, 2022
atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment FailureLaure Fournier Le Ray, Alexandra Aubry, Wladimir Sougakoff, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2024
Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosisThomas Maitre, Alexandre Godmer, Céline Mory, et al.
The Biochemical Journal|July 23, 2013
Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxesAurélie Bouige, Amélie Darmon, Jérémie Piton, et al.
Pageof 10